Triple A syndrome (Allgrove syndrome, MIM No. 231550) is a rare autosomal recessive disorder characterised by ACTH-resistant adrenal insufficiency, achalasia of the cardia, and alacrimia. The triple A gene has been previously mapped to chromosome 12q13 in a maximum interval of 6 cM between loci D12S1629 and D12S312. Using linkage analysis in 12 triple A families, mostly originating from North Africa, we confirm that the disease locus maps to the 12q13 region (Z max = 10.89 at Θ = 0 for D12S1604) and suggest that triple A is a genetically homogeneous disorder. Recombination events as well as homozygosity for polymorphic markers enabled us to reduce the genetic interval to a 3.9 cM region. Moreover, total linkage disequilibrium was found at the D12S1604 locus between a rare allele and the mutant chromosomes in North African patients. Analysis of markers at five contiguous loci showed that most of the triple A chromosomes are derived from a single founder chromosome. As all markers are located in a 0 cM genetic interval and only allele 5 at the D12S1604 locus was conserved in mutant chromosomes, we speculate that the triple A mutation is due to an ancient Arabian founder effect that occurred before migration to North Africa. Since we also found linkage disequilibrium at D12S1604 in two patients from Southern Europe (France and Spain), the founder effect might well extend to other Mediterranean countries. Taking advantage of a YAC contig encompassing the triple A minimal physical region, the triple A gene was mapped to a 1.7 Mb DNA fragment accessible to gene cloning. European Journal of Human Genetics (2000) 8, 613-620.
Introduction
Triple A syndrome (Allgrove syndrome, MIM no. 231550) is a rare autosomal recessive disorder characterised by ACTHresistant adrenal insufficiency, achalasia of the cardia, and alacrimia. [1] [2] [3] [4] Whilst triple A syndrome is usually expressed during the first decade of life with severe hypoglycemic episodes, late onset with progressive neurological symptoms such as autonomic and peripheral neuropathies, dementia, and cerebellar ataxia has been reported. [5] [6] [7] Both the progressive neurologic features and the parasympathic innervation of most involved organs suggested mutation of a gene encoding either a neuromodulator or a neurotrophic factor.
In particular, based on overlaps between triple A syndrome and familial glucocorticoid deficiency, the ACTH receptor and the vasoactive intestinal peptide genes have been excluded as candidate genes. 8 Systematic linkage screening in triple A syndrome families showed linkage of the disease locus to chromosome 12q13 in a maximum genetic interval spanning 6 cM between the D12S1629 and D12S312 loci. 9 However, no candidate gene was thought to lie in this region whose genetic length was not amenable to positional cloning. Using the combination of homozygosity mapping and linkage disequilibrium in a highly inbred North African families, we localised the triple A locus to a 0 cM interval at the D12S1604 locus and confirmed genetic homogeneity of this condition. We subsequently developed a YAC/PAC contig encompassing the triple A minimal region that was mapped to a 1.7 Mb DNA fragment accessible to gene cloning.
Patients and methods

Families
Inclusion criteria for triple A syndrome families were the presence of all the following:
(i) laboratory proven glucocorticoid deficiency,
(ii) alacrimia with positive Schirmer test, and (iii) achalasia of the cardia with positive manometry or barium study in at least one family member.
A total of 12 families including 7 multiplex kindreds were studied and blood samples were collected from 22 patients and 45 relatives, with informed consent. Seven families originated from North Africa: Algeria (five families) and Tunisia (two families, Figure 1 ). Family M6 was split into two kindreds: M6a with consanguineous and M6b with nonconsanguineous parents. The other families originated from France (family 8), Spain (family 9), Croatia (families 10-11), and Turkey (family 12, Figure 1 ).
Genotyping
Genomic DNA was extracted according to standard procedures. Linkage studies were performed using ten contiguous microsatellite DNA markers mapping to the 12q13 region and spanning a 3.9 cM interval (sex average distance) in the following order: tel /D12S312 -D12S103 -D12S325 -D12S1586 -D12S1651 -D12S1604 -D12S1618 -D12S359 -D12S96 -D12S368/ cen. 10 Marker informativity varied from 61 to 83%. PCR amplification of the microsatellite markers was carried out with 100 ng genomic DNA in a 25-µl total reaction volume containing: 0. 
Statistical analyses
Linkage of the triple A locus was tested assuming that the disease is inherited as an autosomal recessive trait with full penetrance (normal allele frequency f = 0.999). Two-point lod scores were calculated for linkage between the triple A locus and each of the microsatellite DNA markers using the Linkage Package (Version 5.1, M-LINK program). Allele frequencies were compared between mutant (n = 16) and normal chromosomes (n = 14) in nuclear families. We also compared the allele frequencies at the D12S1604 locus between mutant chromosomes and 88 control chromosomes from 44 unrelated and unselected North African individuals.
Significance of linkage disequilibrium was tested using the standard 2 test. An attempt was made to estimate the age of the triple A mutation from linkage disequilibrium of flanking markers. The mutation occurred on an ancestor haplotype that could be reconstructed by comparing the distinct family haplotypes. The number of generations that had elapsed since the appearance of the triple A mutation in the North African population (ie the earliest common ancestor) was estimated.
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YAC and PAC screening
For physical mapping of the triple A locus, 5 YACs, of the 12q13 region were first identified (CEPH-Généthon database, 13 ), namely YACs 813h5 (600 kb), 975f5 (270 kb), 928a12 (1330 kb), 790f7 (570 kb), and 903f1 (length unknown). The ten polymorphic markers mapping to the critical region between loci D12S368 and D12S312 were ordered on the overlapping YACs contig by PCR amplification.
PACs from the Genome System Library® (St Louis, MI, USA) were screened with the AFMa189yd9 probe at the D12S1604 locus. The presence of polymorphic DNA markers was established by PCR amplification on PAC DNA isolated as previously described. 14 The length of YAC and PACs was evaluated by field inversion gel electrophoresis (FIGE Mapper, Biorad, Richmond, CA, USA) under the following conditions: forward 180 V, reverse 120 V, with a 0.1-2 s switch time for 16 h at 20°C.
15
Physical mapping of the neurokinin B gene
The neurokinin B gene has been mapped to the 12q13 region and could be regarded as an interesting candidate gene for triple A syndrome. 16, 17 The presence of the neurokinin B gene Table 1 .
Fine linkage disequilibrium mapping of triple A syndrome y S Hadj-Rabia et alin the triple A PAC/YAC contig was tested by PCR amplification using oligonucleotide primers for exons 2-5 (primers available on request).
Results
Genotyping Two-point lod scores between the triple A locus and 12q13 polymorphic markers in 12 triple A families are shown in Table 1 . The maximum lod score was obtained for marker AFMa189yd9 at the D12S1604 locus (Z = 10.89 at Θ = 0%), indicating that this marker was completely linked to the disease in the families studied. Haplotype analyses allowed characterisation of a total of four obligate recombination events in four families. The recombinant mutant chromosomes in affected individuals J and K (families M6a and M6b, Figure 1 ), and S (family 11, Figure 1 ) placed the proximal boundary of the triple A region at the D12S368 locus (Table 1 ; Figure 1 ). A recombination event in patient H (family M5, Figure 1 ) suggested that the distal boundary was at the D12S312 locus (Table 1 ; Figure 1 ). Thus, based on meiotic recombinant mapping, the triple A syndrome locus was refined to a genetic interval of 3.9 cM between loci D12S368 and D12S312. Moreover, homozygosity was observed for each of the markers between the D12S368 and D12S312 loci in each of the 13 affected individuals in the seven consanguineous families studied (M1, M3 to M5, M6a, M7, 8 and 12; Figure 1 and Table 1 ). However, the two patients of the M6a family showed heterozygosity at locus D12S103 ( Figure 1, Table 1 ), supporting the hypothesis that the telomeric boundary was distal to the D12S325 locus (the genetic distance between D12S103 and D12S325 is unknown).
Comparison of mutant chromosomes in families originating from North Africa suggested a common ancestral mutant haplotype. Indeed, Table 1 shows that 10 patients of North African origin had homozygosity for a single allele at each of the contiguous polymorphic loci allowing definition of a common mutant haplotype, namely: 5 (D12S1604)-2 (D12S1651)-5 (D12S1586)-4 (D12S325). In agreement with this, patients B and C in non-consanguineous family M2 (Figure 1 ) harboured this haplotype on their maternal mutant chromosome only. The mutant haplotype was restricted to the D12S1604 locus when affected individuals of M1 and M2 were included (Figure 1) . Therefore all patients originating from North Africa showed homozygosity for a unique allele at the D12S1604 locus (allele 5), suggesting a founder effect for a mutant triple A gene in families of North African origin (M1 to M7). In order to test this hypothesis, we estimated the frequency of polymorphic alleles both in normal chromosomes (n = 14) and in a series of 88 chromosomes from unrelated controls of the same ethnic background ( Table 2 ). The distribution of alleles 5, 2, 5, and 4 at loci D12S1604, D12S1651, D12S1586 and D12S325 ì ï ï í ï ï î ì í î (Table 2 ). In particular, allele 5 at the D12S1604 locus displayed strong linkage disequilibrium with the triple A mutant allele (100% in mutant chromosomes vs 9.1% in control North African chromosomes, P < 0.001). Moreover, homozygosity for allele 5 at the D12S1604 locus was observed in patients N and O from French and Spanish families (Families 8 and 9, respectively, Figure 1) , suggesting that the linkage disequilibrium between the D12S1604 and the triple A loci, and hence the founder effect, might extend to other Mediterranean countries (frequency of allele 5 in the French population: 12%).
Physical mapping and neurokinin gene exclusion
The entire genetic interval encompassing the triple A locus lies in a three YAC contig spanning 2.4 Mb (813h5, 927f5, 903f1; Figure 2 ). The region with full linkage disequilibrium mapped to the 903f1 YAC whose size was 1700 kb. To refine this physical interval, two PACs (PAC 34 and 35) were obtained from the Genome System Library® screened with the AFMa189yd9 probe at the D12S1604 locus. Interestingly, marker AFMb069we9 at the D12S1651 locus, which was in partial linkage disequilibrium (12/16 chromosomes), was also present on both PACs. The size of PAC 34 was 66 kb (not shown). This result suggests that PAC 34 encompasses at least one extremity of the triple A gene. The neurokinin B gene was excluded from the candidate region since no PCR signal could be obtained with any of the four exons tested using PACs 34 and 35 and the YAC contig (not shown). Frequencies are indicated for mutant chromosomes, and for normal chromosomes originating from the parents of affected individuals, as well as from 44 unrelated individuals with the same ethnic background (control chromosomes).
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Discussion
Triple A syndrome (Allgrove syndrome) is a highly heterogeneous autosomal recessive disorder with high lethality. 1 The triple A gene has been previously mapped to chromosome 12q13 in a 6 cM interval between loci D12S1629 and D12S312. 9, 18 In order to refine this interval, we have extended linkage analysis to 12 triple A families using additional polymorphic DNA markers chosen in the vicinity of the triple A gene locus. By genotyping 22 affected individuals and their 45 relatives, we confirmed that the triple A gene maps to the 12q13 region and suggest that triple A is probably a genetically homogeneous disorder in patients of North African ancestry. Using conventional recombinational mapping, we were able to narrow the triple A region to a 3.9 cM interval flanked by marker loci D12S368 and D12S312. Then, homozygosity mapping allowed us to place the telomeric boundary proximal to D12S103. However, only linkage disequilibrium allowed us to make an accurate genetic refinement of the triple A locus. Indeed, linkage disequilibrium could be regarded as the most powerful tool in genetic mapping for positional cloning of disease genes.
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Linkage disequilibrium mapping takes advantage of ancestral recombinational events that have occurred during the history of a population. 20, 21 Since most of the disease chromosomes in an inbred small population carry a single mutation, the smaller the region with linkage disequilibrium, the older the mutation. In fact, a strong linkage disequilibrium was detected between the triple A locus and several polymorphic DNA markers loci in all North African kindreds tested. In particular, total linkage disequilibrium was found at the D12S1604 locus (16/16) . This finding supports the hypothesis of a unique mutation resulting in triple A syndrome in North Africa. Conversely, only partial disequilibrium (12/16) was found at loci that are either telomeric to D12S1604 (D12S1651, D12S1586, D12S325, D12S103) or centromeric to D12S1618 (6/16). Interestingly, these five contiguous polymorphic markers map within a 0 cM genetic interval. Further evidence regarding the localisation of the triple A gene was obtained by constructing haplotypes for the polymorphic markers in the critical region. Analysis of markers at loci D12S1604, D12S1651, D12S1586, and D12S325 showed that most of the mutant triple A chromosomes may be derived from a single founder chromosome carrying the 5-2-5-4 haplotype, which was reduced to only one marker at locus D12S1604 in all North African triple A families. Both the geographical distribution of carriers of the mutation (Algeria and Tunisia) and the size of the common ancestral haplotype, indicate that the triple A mutation in the North African population is very old. Our data suggest that the founder mutation for the triple A mutation occurred in the Arabian population a long time before the migration for the triple A mutation to North Africa. Computation suggested that the most likely number of generations that have elapsed since the appearance of the mutation is 100-110. Assuming that a generation is equivalent to 24 years, 12, 22 this would indicate that the triple A mutation is at least 2400 years old (not shown). Moreover, since linkage disequilibrium at D12S1604 was also present in two patients from Southern Europe (France and Spain), the founder effect might well extend to other Mediterranean countries.
Inter-and intra-familial clinical heterogeneity of triple A syndrome supports the existence of allelic variation at a single locus or of modifier genes, rather than genetic heterogeneity. 2 Interestingly, both the full blown (MIM no.
231550) and partial (achalasia-alacrimia, MIM no. 200440) triple A phenotypes co-segregate in single large triple A kindreds such as family M6 in our series (Figure 1 ), suggesting genetic homogeneity for these two conditions that have been separated in the MIM catalogue. Both genetic homogeneity and fine genetic mapping now allow prenatal diagnosis of the triple A syndrome to be proposed based on indirect genetic analysis. In addition, since all our North African families exhibited linkage disequilibrium, homozygosity for allele 5 at the D12S1604 locus may help in diagnosing triple A syndrome in North African patients, since the syndrome is still very difficult to prove based on clinical and laboratory criteria alone.
Finally, physical mapping allowed us to map the triple A gene to a 1.7 Mb YAC (YAC 903f1). This YAC contains the telomeric recombinant boundary of obligate recombinants as well as each of the four loci in strong linkage disequilibrium with the triple A locus. The YAC also contains both D12S1604 and D12S1651 loci that span the 0 cM interval in a 66 kb PAC (PAC 34). Since D12S1604 and D12S1651 show, respectively, a complete and partial linkage disequilibrium, it is thus likely that the triple A gene may be completely or partially contained in the PAC 34. For these reasons we are currently carrying out DNA sequencing and EST identification as a first step towards cloning the triple A gene.
